Summit Therapeutics Inc. · NASDAQ:SMMT

Soni Manmeet Singh bought 50,000 Summit Therapeutics Inc. shares (Form 4)

Traded Jun 4, 2026 · Filed Jun 4, 2026

On Jun 4, 2026, Soni Manmeet Singh (Director, COO and CFO) bought 50,000 Summit Therapeutics Inc. shares at an average US$14.45 for US$722K, leaving 3,123,603 shares. Filed Jun 4, 2026 (Form 4).

Bought
50,000 shares
Price
US$14.45 average (US$14.43 to US$14.46)
Value
US$722K
Holding after
3,123,603 shares
Trading plan
No
Role
Director, COO and CFO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 4, 2026Common StockBuy25,000US$14.463,098,603Direct
Jun 4, 2026Common StockBuy25,000US$14.433,123,603Direct

Source

View original at SEC

Related